Back to mobile site

BMO Capital on National Health Investors (NHI): 'Acquisitions Accelerating; SHOP Growth Execution Key'

September 23, 2026 8:54 AM EDT Send to a Friend
BMO Capital analyst Juan C. Sanabria reiterated an Outperform rating and $80.00 price target on National Health Investors (NYSE: NHI).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login